This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by GOLDSTEIN, B. J. Articles by KAHN, C. R. Search for Related Content PubMed PubMed Citation Articles by GOLDSTEIN, B. J. Articles by KAHN, C. R.

Insulin Receptor Messenger Ribonucleic Acid Sequence Alterations Detected by Ribonuclease Cleavage in Patients with Syndromes of Insulin Resistance^*

BARRY J. GOLDSTEIN and C. RONALD KAHN

Research Division, Joslin Diabetes Center Boston, Massachusetts 02215
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: C. Ronald Kahn, M.D., Joslin Diabetes Center, One Joslin Place, Boston, Massachusetts 02215.

We used a ribonuclease cleavage assay to screen for insulin receptor mRNA sequence alterations in 12 patients with syndromes of severe insulin resistance. Uniformly labeled [³²P]antisense RNA probes complementary to insulin receptor mRNA were prepared by an SP6 or T7 RNA polymerase transcription reaction. Four probes ranging in size from 670–1470 bases were used to examine the entire 4.2-kilobase receptor protein-coding region. Patient RNA samples were hybridized to individual probes in solution, and mismatched sequences were detected by susceptibility to cleavage by a mixture of RNAses A and T1. The method was validated with insulin receptor mRNAs from cells transfected with cDNA constructs bearing known point and deletion mutations. Alterations in the insulin receptor mRNA sequence of two patients were detected. A patient with the type A syndrome of severe insulin resistance (A2-Boston) had a mutation in the insulin receptor β-subunit mRNA sequence that localized to the region coding for amino acid residues 1174–1211 near the tyrosine kinase domain. The second alteration was a sequence polymorphism in the insulin receptor -subunit mRNA in a patient with lipoatropic diabetes (LA-2) that localized to a region within amino acids 268–272. Direct sequence analysis revealed that the ribonuclease cleavage sites in patients A2-Boston and LA-2 were due to distinct single base changes in the insulin receptor gene and mRNA. Additional insulin receptor mRNA sequence polymorphisms were also identified as mismatches between the labeled RNA probes used and mRNA from several cultured human cell types. This study demonstrates that ribonuclease cleavage can rapidly detect and localize insulin receptor mRNA sequence mutations and polymorphic variations as small as single base changes. Further analysis of insulin receptor mRNA sequence alterations identified in this way may elucidate a possible genetic basis for functional insulin receptor defects in patients with severe insulin resistance and can also reveal some insulin receptor sequence polymorphisms that occur in the population at larg

^* This work was supported by NIH Grants DK-31036, DK-33201, and DK-36836 (Joslin Diabetes Endocrinology Research Center) and a Pfizer Biomedical Award (to C.R.K.).

Pfizer Postdoctoral Fellow in Diabetes.

Received October 28, 1988.